| abstract |
Describes methods for treating, preventing or managing myelodysplastic syndromes. Certain methods include an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, inclusion compound, or prodrug thereof, alone or as a second active ingredient, and / or Or administration in combination with blood or cell transplantation. Certain second active ingredients can affect blood cell formation. Also described are pharmaceutical compositions, single dose dosage forms, and kits suitable for use in the methods of the invention. |